Synthesis and biological evaluation of a trisaccharide repeating unit derivative of Streptococcus pneumoniae 19A...

Area of Science:

• Carbohydrate Chemistry
• Vaccine Development
• Immunology

Background:

• Streptococcus pneumoniae (SP) is a major cause of global mortality and morbidity, especially in children.
• Increasing drug resistance in SP necessitates novel therapeutic and preventative strategies, such as vaccination.
• Serogroup 19, particularly serotypes 19F and 19A, is frequently implicated in invasive pneumococcal diseases.

Purpose of the Study:

• To synthesize an aminopropyl derivative of the Streptococcus pneumoniae 19A trisaccharide repeating unit.
• To compare synthetic strategies for efficient trisaccharide preparation.
• To evaluate the biological activity and binding affinity of the synthesized trisaccharide.

Main Methods:

• Exploration of two distinct synthetic routes for the trisaccharide repeating unit.
• Chemical synthesis of an aminopropyl derivative of the SP 19A trisaccharide.
• Evaluation of trisaccharide binding affinity with anti-19A and anti-19F sera.

Main Results:

• Successful synthesis of the SP 19A trisaccharide derivative using optimized synthetic strategies.
• Demonstrated binding affinity of the trisaccharide to specific anti-pneumococcal sera.
• Insights into the structure-activity relationship between the trisaccharide and immunoreactivity.

Conclusions:

• The developed synthetic approach provides a foundation for creating more complex biopolymers and saccharide conjugates.
• The findings contribute to understanding SP immunoreactivity for potential vaccine development.
• This research supports the pursuit of novel vaccine components against invasive pneumococcal diseases.